Recent

% | $
Quotes you view appear here for quick access.

ACCESS PHARMACEUTICL Message Board

  • lizdan_7 lizdan_7 Dec 10, 2010 9:29 AM Flag

    Here for those with questions

    Here is a Company that right now is under investigation

    Press Release Source: Bernstein Liebhard LLP On Thursday December 9, 2010, 1:03 pm EST

    NEW YORK--(BUSINESS WIRE)-- Bernstein Liebhard LLP has commenced an investigation into possible violations of the law by certain officers and directors of Geron Corporation (“Geron” or the “Company”) (NASDAQ:GERN - News).

    The investigation focuses on allegations that certain statements made by the Company concerning Geron’s business and operations were materially false and/or misleading.

    You see that ACCP has to be honest by saying

    We cannot assure you that we will ever be able to generate significant product revenue or achieve or sustain profitability

    As the the poster has said they have to say this.
    When they start selling and making Money this should all change.

    I have been posting that time is our only enemy here. Looks like those who have waited are going to be happy.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • stinky, you don't actually think anyone would believe you owned ACCP shares from Jan.08 to Sept.09 do you? You FAT, STUPID LYING GREASY TURD?

    • Skiidady

      Do not worry I know his many ID, and the fool never understood the difference between share dumped onto the public ( COIN WENT FROM 18 million to 90 million shares, and management never bought any)and STINKY was a buyer, and the difference when ACCP management puts THEIR money in.
      STINKY IS A #$%$ PERIOD.

    • Rheingold, denis_bb_goddard is DWESR who is only here because Robertel enraged him by pointing out what a POS COIN is on the COIN board. Poor clown probably lost a bundle and for some reason holds Robert responsible! Today could be a great purging of weak hands that didn't realize dilution was going to happen at some time. I consider it fairly bullish the dilution was so minor. This COULD be the last dilution.

    • received it an ACCP HQ is probably having a good luagh

      received it an ACCP ---- Ha Ha Ha Ha

      having a good luagh - - - - Ha Ha Ha Ha

      You posted this as a joke Right. Please tell me it was a joke because of MY 6 Year Old Post - - - - Ha Ha Ha Ha

    • You may want to read your posts before you stick your foot in you mouth.
      the board doesn't want to hear yoputr bullsheet

      hear yoputr
      Ha Ha Ha Ha - - - - yoputr bullsheet Ha Ha Ha Ha

    • the board doesn't want to hear yoputr bullsheet. And you write like a 6 year old. If you did compose that e-mail, whoever received it an ACCP HQ is probably having a good luagh.

    • "We cannot assure you that we will ever be able to generate significant product revenue or achieve or sustain profitability."

      I work in legal/compliance. 100% of all small pharma or biotech companies with early-stage products in FDA trials must make include this statement in their official public filings. No such company would ever guarantee that it is going to be profitable if it has no product on the market or every potential product is still awaiting FDA approval. This company should be profitable given the market size of its current product for sale, but it cannot gurantee such a claim.

      • 2 Replies to rheingoldismybeer
      • "I work in legal/compliance."

        Ohhhh, that qualifies you, abolutely!

        So what did your legal/compliance 101 course say about the REST of the 10Q:


        As of November 15, 2010, we did not have enough capital to achieve our long-term goals. A failure to obtain necessary additional capital in the future could jeopardize our operations and our ability to continue as a going concern.

        Net loss allocable to common stockholders for the first nine months of 2010 was $11,180,000, or a $0.73 basic and diluted loss per common share, compared with a loss of $9,802,000, or a $0.86 basic and diluted loss per common share for the same period in 2009, an increased loss of $1,378,000.

        Net loss allocable to common stockholders for the third quarter of 2010, was $13,171,000, or a $0.83 basic and diluted loss per common share, compared with a loss of $4,542,000, or a $0.37 basic and diluted loss per common share for the same period in 2009, an increased loss of $8,629,000.

        We have generally incurred negative cash flows from operations since inception, and have expended, and expect to continue to expend in the future, substantial funds to complete our planned product development efforts. Since inception, our expenses have significantly exceeded revenues, resulting in an accumulated deficit as of September 30, 2010 of $252,987,000.

        +++++++++

        "I'm not a stock analyst, but I play one on the ACCP board," right?

      • Well said Thank You.

 
ACCP
0.00(0.00%)